The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies (Q73470000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Thompson WD

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Li WW

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Maragoudakis M

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

330-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10685066%20AND%20SRC:MED&resulttype=core&format=json

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

21 January 2018

Arterial gene therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Observations on the growth of blood vessels into the cornea; application of a new experimental technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Local Extravascular Growth Factor Delivery in Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Angiogenesis and angiogenesis inhibitors in paediatric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Factors controlling ocular angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Role of tumor necrosis factor-α and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Fibrin as a factor in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

A flanking attack on cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Clinical trials of anti-vascular agent group B Streptococcus toxin (CM101)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: vascular endothelial growth factor/basic fibroblast growth factor and interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

CM101, a polysaccharide antitumor agent, does not inhibit wound healing in murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28200002%29190%3A3%3C330%3A%3AAID-PATH588%3E3.0.CO%3B2-4

10.1002/(SICI)1096-9896(200002)190:3<330::AID-PATH588>3.0.CO;2-4

21 January 2018

Identifiers

DOI

0 references

1 reference